Clinical and Experimental Hepatology
eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2025
vol. 11
 
Share:
Share:
abstract:
Review paper

Hepatic involvement in major respiratory viral infections

Piotr Rzymski
1
,
Krystyna Dobrowolska
2
,
Michał Brzdęk
3, 4
,
Dorota Zarębska-Michaluk
2
,
Robert Flisiak
5

  1. Department of Environmental Medicine, Poznan University of Medical Sciences, Poznan, Poland
  2. Department of Infectious Diseases and Allergology, Jan Kochanowski University, Kielce, Poland
  3. Department of Gastroenterology, Medical University of Lodz, Lodz, Poland
  4. Collegium Medicum, Jan Kochanowski University, Kielce, Poland
  5. Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Białystok, Poland
Clin Exp HEPATOL 2025; 11, 2: 121-128
Online publish date: 2025/06/09
View full text Get citation
 
PlumX metrics:
Common respiratory viral pathogens, including SARS-CoV-2, influenza viruses, and respiratory syncytial virus (RSV), can lead to extrapulmonary manifestations, including clinically significant liver involvement. This review synthesizes current evidence on the epidemiology, mechanisms, and prognostic implications of hepatic injury associated with these viruses. We discuss the distinct mechanisms of liver dysfunction, ranging from the possibility of direct viral infection of hepatocytes to indirect effects of systemic inflammatory responses, hypoxic injury, preexisting liver disease, and drug-related hepatotoxicity. Liver involvement in COVID-19 has been explored to a much greater extent than in the case of influenza or RSV infections, highlighting the need for further studies. Clinically, recognizing liver involvement in respiratory viral infections is crucial, particularly in high-risk populations such as patients with chronic liver disease, transplant recipients, and children. We underscore the importance of integrating hepatic evaluation into the clinical approach to severe respiratory viral illnesses to improve patient outcomes.
keywords:

liver dysfunction, respiratory syncytial virus, SARS-CoV-2, influenza, hepatology

Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.